第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。第3工作组：肥厚型心肌病、心肌炎及其他心肌心包疾病与二尖瓣脱垂 - Suppr

Suppr

超能文献

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse.

作者信息

Maron B J, Isner J M, McKenna W J

出版信息

J Am Coll Cardiol. 1994 Oct;24(4):880-5. doi: 10.1016/0735-1097(94)90844-3.

DOI:10.1016/0735-1097(94)90844-3

PMID:7930220

Abstract

摘要

相似文献

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。第3工作组：肥厚型心肌病、心肌炎及其他心肌心包疾病与二尖瓣脱垂

J Am Coll Cardiol. 1994 Oct;24(4):880-5. doi: 10.1016/0735-1097(94)90844-3.

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S261-7.

Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force III: Hypertrophic cardiomyopathy, other myopericardial diseases and mitral valve prolapse.

J Am Coll Cardiol. 1985 Dec;6(6):1215-7. doi: 10.1016/s0735-1097(85)80203-5.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.心血管异常竞技运动员的资格认定与取消资格建议：特别工作组3：肥厚型心肌病、致心律失常性右室心肌病及其他心肌病，以及心肌炎：美国心脏协会和美国心脏病学会的科学声明

Circulation. 2015 Dec 1;132(22):e273-80. doi: 10.1161/CIR.0000000000000239. Epub 2015 Nov 2.

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。特别工作组2：获得性瓣膜性心脏病。

J Am Coll Cardiol. 1994 Oct;24(4):874-80. doi: 10.1016/0735-1097(94)90843-5.

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S254-60.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.心血管异常竞技运动员的资格认定与取消资格建议：特别工作组3：肥厚型心肌病、致心律失常性右室心肌病及其他心肌病、心肌炎：美国心脏协会和美国心脏病学会科学声明

J Am Coll Cardiol. 2015 Dec 1;66(21):2362-2371. doi: 10.1016/j.jacc.2015.09.035. Epub 2015 Nov 2.

Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome.

J Am Coll Cardiol. 2005 Apr 19;45(8):1340-5. doi: 10.1016/j.jacc.2005.02.011.

Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis.关于心肌病、心肌炎和心包炎患者参与竞技运动和休闲体育活动的建议。

Eur J Cardiovasc Prev Rehabil. 2006 Dec;13(6):876-85. doi: 10.1097/01.hjr.0000238393.96975.32.

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 4: systemic hypertension.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。第4工作组：系统性高血压。

J Am Coll Cardiol. 1994 Oct;24(4):885-8. doi: 10.1016/0735-1097(94)90845-1.

引用本文的文献

Gene Expression and Athlete's Heart: A Study in Middle-Aged Endurance Athletes.基因表达与运动员心脏：一项针对中年耐力运动员的研究。

Genes (Basel). 2025 Sep 18;16(9):1104. doi: 10.3390/genes16091104.

Scaling left ventricular mass in adolescent female soccer players.青少年女足运动员左心室质量的缩放。

BMC Pediatr. 2020 Apr 13;20(1):157. doi: 10.1186/s12887-020-02043-7.

Return to Sport for Skeletally Immature Athletes After ACL Reconstruction: Preventing a Second Injury Using a Quality of Movement Assessment and Quantitative Measures to Address Modifiable Risk Factors.骨骼未成熟运动员前交叉韧带重建术后重返运动：通过运动质量评估和定量测量来解决可改变的风险因素，预防二次损伤。

Orthop J Sports Med. 2017 Apr 20;5(4):2325967117700599. doi: 10.1177/2325967117700599. eCollection 2017 Apr.

Arrhythmogenic right ventricular cardiomyopathy (ARVC): case report and review of literature.致心律失常性右室心肌病（ARVC）：病例报告及文献综述

Heart Asia. 2014 Oct 1;6(1):145-9. doi: 10.1136/heartasia-2014-010569. eCollection 2014.

National Athletic Trainers' Association position statement: Preparticipation physical examinations and disqualifying conditions.美国国家运动训练师协会立场声明：赛前体格检查与 disqualifying conditions（此处“disqualifying conditions”可能需结合具体语境准确翻译，比如“ disqualifying conditions”可译为“不合格条件” ，但仅从字面看是“取消资格的条件” ）。

J Athl Train. 2014 Jan-Feb;49(1):102-20. doi: 10.4085/1062-6050-48.6.05.

Hypertrophic Cardiomyopathy in a Young Adult with RV Aneurysm: Report of a Rare Finding and Review of the Literature.一名患有右心室动脉瘤的年轻成人的肥厚型心肌病：罕见病例报告及文献综述

Heart Views. 2011 Jul;12(3):112-7. doi: 10.4103/1995-705X.95067.

Cardiomyopathy in children.儿童心肌病

Curr Treat Options Cardiovasc Med. 2001 Oct;3(5):403-13. doi: 10.1007/s11936-001-0030-9.

Hypertrophic cardiomyopathy as a cause of sudden death.肥厚型心肌病作为猝死的一个原因。

Herz. 2009 Jun;34(4):305-14. doi: 10.1007/s00059-009-3248-z.

Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.加拿大心血管学会关于心力衰竭的共识会议指南——2008年更新：心力衰竭患者护理过渡的最佳实践，以及心肌病的识别、调查和治疗。

Can J Cardiol. 2008 Jan;24(1):21-40. doi: 10.1016/s0828-282x(08)70545-2.

Management of hypertrophic cardiomyopathy.肥厚型心肌病的管理

BMJ. 2006 May 27;332(7552):1251-5. doi: 10.1136/bmj.332.7552.1251.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验